Both in Biotechnology
Kyverna Therapeutics vs Agenus
Over the past year KYTX returned −24.1% and AGEN returned +64.5%; their daily moves had a correlation of 0.16.
KYTX −24.1% AGEN +64.5%Growth of $1, one year, split-adjusted
| Metric | KYTX | AGEN |
|---|---|---|
| Price | $5.22 | $6.53 |
| Market cap | $322.8M | $294.9M |
| Today | −7.94% | −4.53% |
| 1 month | −16.1% | −21.9% |
| 6 months | −42.0% | +62.4% |
| Year to date | −44.5% | +108.0% |
| 1 year | −22.7% | +71.4% |
| Revenue growth (YoY) | — | +34.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | 3.2× |
| Price / sales | — | 2.2× |
| Net cash | $174.4M | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 59.9% | 88.4% |
| Short % of float | 26.6% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).